Strychnine

Strychnine

SCHEMBL235087

O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46.O=S(=O)(O)O

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Strychnine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SCN1A known ✓ P35498 1/20 0.91
SCN2A known ✓ Q99250 1/20 0.91
SCN3A known ✓ Q9NY46 1/20 0.91
CHRM1 known ✓ P11229 1/20 0.66
GLRA1 P23415 15/20 0.91
GLRB P48167 13/20 0.91
CYP3A4 P08684 2/20 0.91
MEN1 O00255 2/20 0.91
KMT2A Q03164 2/20 0.91
TAS2R10 Q9NYW0 2/20 0.91
TAS2R46 P59540 1/20 0.91
SMN1; SMN2 Q16637 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Strychnine SCHEMBL29729432 1.00 GLRA1 (0.91) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL10983033 1.00 GLRA1 (0.91) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL25257047 0.99 GLRA1 (0.90) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL4957823 0.97 GLRA1 (0.85) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL21985190 0.96 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL29362678 0.96 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL29352583 0.96 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL93798 0.96 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL12549549 0.96 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A
Strychnine SCHEMBL14047653 0.96 GLRA1 (1.00) GLRA1GLRBCYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108524513-B Application of strychnine sulfate, antibacterial composition, application of strychnine sulfate and antibacterial preparation 湘潭大学 2020-04-07 CN claimed
CN-108524513-A The application of strychnine sulfate and bacteria inhibiting composition and its application and inhibiting-bacteria preparation 湘潭大学 2018-09-14 CN claimed
CN-107759601-A A kind of preparation method of JAK inhibitor and its salt 苏州旺山旺水生物医药有限公司 2018-03-06 CN claimed
CN-107759623-A Intermediate of JAK inhibitor and preparation method thereof 苏州旺山旺水生物医药有限公司 2018-03-06 CN claimed
EP-2380850-B1 MODIFIED SODIUM-MONTMORILLONITE, PREPARING METHOD AND USES THEREOF HAILISHENG PHARMACEUTICAL CO LTD (CN) 2016-10-19 EP claimed
US-9095542-B2 Modified sodium-montmorillonite, preparation method and uses thereof HAILISHENG PHARMACEUTICAL CO., LTD (CN) 2015-08-04 US claimed
CN-104072505-A Method for extracting brucine and strychnine simultaneously NANJING ZELANG MEDICAL TECH CO 2014-10-01 CN claimed
EP-1747775-B1 THE DISPERSIBLE MONTMORILLONITE TABLET AND ITS PREPARATION TECHNOLOGY SHANDONG LUYE PHARM CO LTD (CN) 2013-06-26 EP claimed
US-8337889-B2 Smectite dispersible tablets and the preparation thereof SHANDONG LUYE PHARMACEUTICAL CO., LTD. (CN) 2012-12-25 US claimed
CN-101972259-B Brucine and application of derivatives thereof in preparation of drugs for treating alcoholic abuse and dependence UNIV BEIJING 2012-04-25 CN claimed
US-20120003328-A1 MODIFIED SODIUM-MONTMORILLONITE, PREPARATION METHOD AND USES THEREOF HAILISHENG PHARMACEUTICAL CO., LTD (CN) 2012-01-05 US claimed
EP-2380850-A1 MODIFIED SODIUM-MONTMORILLONITE, PREPARING METHOD AND USES THEREOF Hailisheng Pharmaceutical Co., Ltd (CN) 2011-10-26 EP claimed
US-20080038337-A1 Smectite DispersibleTablets and the Preparation Thereof SHANDONG LUYE PHARMACEUTICAL CO., LTD. (CN) 2008-02-14 US claimed
EP-1747775-A1 THE DISPERSIBLE MONTMORILLONITE TABLET AND ITS PREPARATION TECHNOLOGY SHANDONG LUYE PHARMACEUTICAL CO., LTD. (CN) 2007-01-31 EP claimed
CN-1280158-C Household products based on petroleum distillate JOHNSON & SON INC S C (US) 2006-10-18 CN claimed
CN-1589218-A Household products based on petroleum distillate JOHNSON & SON INC S C (US) 2005-03-02 CN claimed
CN-111050688-B Waste disposal system and waste receptacle for receiving and disposing of pharmaceutical waste 史赛克公司 2023-05-09 CN disclosed
CN-115282190-A A skin antibacterial liquid containing plant extract and its preparation method 王瑶英 2022-11-04 CN disclosed
US-3935211-A CNS DEPRESSANT AMERICAN CYANAMID COMPANY (US) 1976-01-27 US disclosed
US-3933794-A CENTRAL NERVOUS SYSTEM DEPRESSANTS THE UPJOHN COMPANY (US) 1976-01-20 US disclosed